Compare VALE & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VALE | VEEV |
|---|---|---|
| Founded | 1942 | 2007 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Computer Software: Prepackaged Software |
| Sector | Basic Materials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.3B | 46.1B |
| IPO Year | 2008 | 2013 |
| Metric | VALE | VEEV |
|---|---|---|
| Price | $11.62 | $306.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 29 |
| Target Price | $15.23 | ★ $323.07 |
| AVG Volume (30 Days) | ★ 35.0M | 1.4M |
| Earning Date | 10-29-2026 | 11-23-2026 |
| Dividend Yield | ★ 5.95% | N/A |
| EPS Growth | N/A | ★ 25.93 |
| EPS | N/A | ★ 3.22 |
| Revenue | N/A | ★ $1,104,081,000.00 |
| Revenue This Year | $6.76 | $15.51 |
| Revenue Next Year | N/A | $12.32 |
| P/E Ratio | ★ $29.09 | $95.25 |
| Revenue Growth | N/A | ★ 28.05 |
| 52 Week Low | $10.96 | $148.05 |
| 52 Week High | $17.94 | $325.99 |
| Indicator | VALE | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 38.65 | 52.19 |
| Support Level | $10.96 | $151.71 |
| Resistance Level | $15.08 | $325.99 |
| Average True Range (ATR) | 0.36 | 8.25 |
| MACD | 0.06 | -2.84 |
| Stochastic Oscillator | 41.40 | 33.35 |
Vale is a large global miner and the world's largest producer of iron ore and pellets. In recent years, the company has sold noncore assets such as its fertilizer, coal, and steel operations to concentrate on iron ore, copper, and nickel. Earnings are dominated by its iron ore business. The base metals division is much smaller, consisting of nickel mines and smelters along with copper mines producing copper in concentrate. In 2024, Vale sold a minority 10% stake in its base metals business, likely the first step in separating base metals and iron ore.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.